Bleeding Diathesis in Patients With Chronic Myelogenous Leukemia Receiving Dasatinib Therapy

BACKGROUND: The most frequent nonhematologic side effects associated with dasatinib therapy in patients with chronic myeloid leukemia (CML) are gastrointestinal, rash, and fluid retention syndromes. However, bleeding has been observed in some patients receiving dasatinib. In the current study, the a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Quintás-Cardama, Alfonso, Kantarjian, Hagop, Ravandi, Farhad, O’Brien, Susan, Thomas, Deborah, Vidal-Senmache, Gabriela, Wierda, William, Kornblau, Steven, Cortes, Jorge
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4180711/
https://ncbi.nlm.nih.gov/pubmed/19280591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24257
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items